Lv4
780 积分 2024-05-20 加入
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
4天前
已完结
Ibrutinib: Pediatric First Approval
5天前
已完结
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
5天前
已完结
PROTACs in platelets: emerging antithrombotic strategies and future perspectives
5天前
已关闭
BTK Inhibitors in Haematology: Beyond B Cell Malignancies
5天前
已完结
Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors
5天前
已完结
Emerging Therapeutics in Chronic Urticaria
6天前
已完结
Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis
6天前
已完结
BTK inhibitors: past, present, and future
6天前
已完结
Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus
6天前
已完结
皖公网安备34019202002308
